欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1931/002
药品名称
Hidroclorotiazida Generis
活性成分
hydrochlorothiazide 25.0 mg
剂型
Tablet
上市许可持有人
Generis Farmacêutica, S.A
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
HCT PUREN 25 mg Tabletten
Netherlands (NL)
Hydrochloorthiazide Aurobindo 25 mg, tabletten
France (FR)
Spain (ES)
Italy (IT)
Poland (PL)
HCTZ Aurovitas
Czechia (CZ)
HCTZ Aurovitas
许可日期
2019/04/24
最近更新日期
2024/03/05
药物ATC编码
C03AA03 hydrochlorothiazide
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
common_pl_clean
Date of last change:2024/03/05
Final Product Information
|
PIL_final
Date of last change:2019/07/19
Final Product Information
|
Labelling_final
Date of last change:2019/07/19
Final Product Information
|
SPC_final
Date of last change:2019/07/19
PAR
|
Summary_PARPAR_propostos_PT_1931_final
Date of last change:2019/07/19
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase